2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis

PHASE2TerminatedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Multiple MyelomaPlasma Cell Neoplasm
Interventions
BIOLOGICAL

filgrastim

16mcg/kg IV daily beginning three days prior to stem cell collection through last day of stem cell collection

DRUG

melphalan

140-200 mcg/kg IV over two days

PROCEDURE

autologous stem cell transplantation

infusion of previously collected stem cells on Day 0

PROCEDURE

stem cell infusion

infusion of previously collected stem cells on Day 0

Trial Locations (1)

02118

Boston University Cancer Research Center, Boston

Sponsors
All Listed Sponsors
lead

Boston Medical Center

OTHER